#USES FACILITYNA REGNUM ***RENAL05.RPT*** 4JAN2005 Modified FY2004 to FY2005 4/19/05 * * #FOREACH FACILITYNA #FOREACH REGNUM IHS DIABETES PROGRAM - RENAL PRESERVATION REPORT FY 2005 FOR ^FACILITYNA [] charts were audited from ^REGNUM:5 patients on the diabetes registry. #ENDFOR #ENDFOR Percent Percent n of group of total ----------------------------------------------------------------------- #USES HTN ACE HTN present (prior dx or mean BP >=130/80) [1,]:4 {100*[1,]/[]}:3% On ACE inhibitor or ARB [1,1]:4 {100*[1,1]/[1,]}:3% Not on ACE inhibitor or ARB [1,2]:4 {100*[1,2]/[1,]}:3% ACE inhibitor/ARB status undetermined [1,3]:4 {100*[1,3]/[1,]}:3% No hypertension present [2,]:4 {100*[2,]/[]}:3% Hypertension status not known [3,]:4 {100*[3,]/[]}:3% ----------------------------------------------------------------------- #USES BPCNTRL Ideal BP (<120/<70) [1]:4 {100*[1]/[]}:3% Target BP (120/70 - <130/<80) [2]:4 {100*[2]/[]}:3% - - - - - - - - - - - - - - - - - - - - - - - - - - Suboptimal BP (130/80 - <140/<90) [3]:4 {100*[3]/[]}:3% (140/90 - <160/<95) [4]:4 {100*[4]/[]}:3% Markedly poor BP (160/95 or higher) [5]:4 {100*[5]/[]}:3% BP category undetermined [0]:4 {100*[0]/[]}:3% #USES BPCODE ACE Dx'd HTN -- controlled (<130/<80) [3,]:4 {100*[3,]/[]}:3% On ACE inhibitor or ARB [3,1]:4 {100*[3,1]/[3,]}:3% Not on ACE inhibitor or ARB [3,2]:4 {100*[3,2]/[3,]}:3% Dx'd HTN -- uncontrolled (130/80 or higher) [4,]:4 {100*[4,]/[]}:3% On ACE inhibitor or ARB [4,1]:4 {100*[4,1]/[4,]}:3% Not on ACE inhibitor or ARB [4,2]:4 {100*[4,2]/[4,]}:3% ----------------------------------------------------------------------- #USES MAP_CODE Mean arterial pressure Less than 90 [1]:4 {100*[1]/[]}:3% 90-95 [2]:4 {100*[2]/[]}:3% 96-100 [3]:4 {100*[3]/[]}:3% 101-105 [4]:4 {100*[4]/[]}:3% 106 or more [5]:4 {100*[5]/[]}:3% Undetermined [0]:4 {100*[0]/[]}:3% ----------------------------------------------------------------------- #USES CREATIN CREATGROUP Serum creatinine (within past 12 months) [1,]:4 {100*[1,]/[]}:3% Creatinine >= 2.0 mg/dl [1,2]:4 {100*[1,2]/[]}:3% Creatinine < 2.0 mg/dl [1,1]:4 {100*[1,1]/[]}:3% Creatinine not tested/unknown [2,]:4 {100*[2,]/[]}:3% #USES GFRCAT Renal Disease Stage Based on Estimated GFR Stage 1 (Normal GFR >=90) [1]:4 {100*[1]/[]}:3% Stage 2 (Mild decrease GFR 60-89) [2]:4 {100*[2]/[]}:3% Stage 3 (Moderate decrease GFR 30-59) [3]:4 {100*[3]/[]}:3% Stage 4 (Severe decrease GFR 15-29) [4]:4 {100*[4]/[]}:3% Stage 5 (Kidney failure: GFR < 15) [5]:4 {100*[5]/[]}:3% Unable to Calculate [9]:4 {100*[9]/[]}:3% #NEWPAGE #USES FACILITYNA #FOREACH FACILITYNA IHS DIABETES PROGRAM - RENAL PRESERVATION REPORT Page 2 FY 2005 FOR ^FACILITYNA #ENDFOR Percent Percent n of group of total ----------------------------------------------------------------------- #USES PROTEINURI ACE Proteinuria present [1,]:4 {100*[1,]/[]}:3% On ACE inhibitor or ARB [1,1]:4 {100*[1,1]/[1,]}:3% Not on ACE inhibitor or ARB [1,2]:4 {100*[1,2]/[1,]}:3% ACE inhibitor/ARB status undetermined [1,3]:4 {100*[1,3]/[1,]}:3% Proteinuria not present [2,]:4 {100*[2,]/[]}:3% Proteinuria status not known [3,]:4 {100*[3,]/[]}:3% #USES PROTEINURI HTN ACE Proteinuria AND any category of htn present [1,1,]:4 {100*[1,1,]/[]}:3% On ACE inhibitor or ARB [1,1,1]:4 {100*[1,1,1]/[1,1,]}:3% Not on ACE inhibitor or ARB [1,1,2]:4 {100*[1,1,2]/[1,1,]}:3% ACE inhibitor/ARB status undetermined [1,1,3]:4 {100*[1,1,3]/[1,1,]}:3% #USES CPROTHTN Proteinuria or htn status not known [3]:4 {100*[3]/[]}:3% ----------------------------------------------------------------------- #USES MICROALB ACE Microalbuminuria present [1,]:4 {100*[1,]/[]}:3% On ACE inhibitor or ARB [1,1]:4 {100*[1,1]/[1,]}:3% Not on ACE inhibitor or ARB [1,2]:4 {100*[1,2]/[1,]}:3% ACE inhibitor/ARB status undetermined [1,3]:4 {100*[1,3]/[1,]}:3% Microalbuminuria not present [2,]:4 {100*[2,]/[]}:3% Microalbuminuria status not known [3,]:4 {100*[3,]/[]}:3% #USES MICROALB HTN ACE Microalbuminuria AND any htn present [1,1,]:4 {100*[1,1,]/[]}:3% On ACE inhibitor or ARB [1,1,1]:4 {100*[1,1,1]/[1,1,]}:3% Not on ACE inhibitor or ARB [1,1,2]:4 {100*[1,1,2]/[1,1,]}:3% ACE inhibitor/ARB status undetermined [1,1,3]:4 {100*[1,1,3]/[1,1,]}:3% #USES CMICHTN Microalbuminuria or htn status not known [3]:4 {100*[3]/[]}:3% ----------------------------------------------------------------------- #USES PROMICRO ACE Either proteinuria OR microalb'uria present [1,]:4 {100*[1,]/[]}:3% On ACE inhibitor or ARB [1,1]:4 {100*[1,1]/[1,]}:3% Not on ACE inhibitor or ARB [1,2]:4 {100*[1,2]/[1,]}:3% ACE inhibitor/ARB status undetermined [1,3]:4 {100*[1,3]/[1,]}:3% Neither proteinuria NOR microalb'uria present[2,]:4 {100*[2,]/[]}:3% On ACE inhibitor or ARB [2,1]:4 {100*[2,1]/[2,]}:3% Not on ACE inhibitor or ARB [2,2]:4 {100*[2,2]/[2,]}:3% ACE inhibitor/ARB status undetermined [2,3]:4 {100*[2,3]/[2,]}:3% ----------------------------------------------------------------------- #USES METCON HRN Glycemic control in pts without overt [,1]:4 {100*[,1]/[]}:3% proteinuria HbA1c <7.0 [1,1]:4 {100*[1,1]/[]}:3% HbA1c 7.0-7.9 [2,1]:4 {100*[2,1]/[]}:3% HbA1c 8.0-8.9 [3,1]:4 {100*[3,1]/[]}:3% HbA1c 9.0-9.9 [4,1]:4 {100*[4,1]/[]}:3% HbA1c 10.0-10.9 [5,1]:4 {100*[5,1]/[]}:3% HbA1c 11.0 and above [6,1]:4 {100*[6,1]/[]}:3% Undocumented [9,1]:4 {100*[9,1]/[]}:3% #NEWPAGE